Dendrite Announces Its Inclusion in the New NASDAQ Global Select Market
30 June 2006 - 5:32AM
Business Wire
Dendrite International, Inc., (NASDAQ:DRTE) a leading provider of
pharmaceutical industry solutions, today announced that it is
included in the new NASDAQ Global Select Market. According to
NASDAQ, The NASDAQ Global Select Market has the highest initial
listing standards of any exchange in the world based on financial
and liquidity requirements. Prior to the change, the company had
been listed on the NASDAQ National Market. Beginning July 3,
NASDAQ-listed companies will be classified under three listing
tiers -- NASDAQ Global Select Market, NASDAQ Global Market, and
NASDAQ Capital Market. NASDAQ also plans to launch indexes based on
these new tiers. "Dendrite is an example of an industry leader that
has achieved superior listing standards, which clearly defines the
essence of the NASDAQ Global Select Market," said Bruce Aust,
Executive Vice President, Corporate Client Group. "NASDAQ is
focused on leading a race to the top in terms of listing
qualifications. In recognizing these companies, we are highlighting
their achievement in meeting the requirements to be included in the
market with the highest listing standards in the world," added Mr.
Aust. NASDAQ announced the new three tier listing classification in
February 2006. All three market tiers will maintain rigorous
listing and corporate governance standards. For additional
information about the NASDAQ Global Select Market, please go to:
www.nasdaq.com/GlobalSelect. About Dendrite Founded in 1986,
Dendrite International (NASDAQ: DRTE) enables sales, marketing,
clinical and compliance solutions for the global, pharmaceutical
industry. The Company's clients are located in more than 50
countries and include the world's top 20 pharmaceutical companies.
For more information, please visit www.dendrite.com. About NASDAQ
NASDAQ is the largest U.S. electronic stock market. With
approximately 3,200 companies, it lists more companies and, on
average, trades more shares per day than any other U.S. market. It
is home to companies that are leaders across all areas of business
including technology, retail, communications, financial services,
transportation, media and biotechnology. NASDAQ is the primary
market for trading NASDAQ-listed stocks. For more information about
NASDAQ, visit www.nasdaq.com or the NASDAQ Newsroom at
http://www.nasdaq.com/newsroom/. Note: Dendrite is a registered
trademark of Dendrite International, Inc. This document may contain
forward-looking statements that may be identified by such
forward-looking terminology as "expect," "believe," "anticipate,"
"will," "intend," "plan," "target," "outlook," "guidance," and
similar statements or variations. Such forward-looking statements
are based on our current expectations, estimates, assumptions and
projections and involve significant risks and uncertainties,
including risks which may result from our dependence on the
pharmaceutical industry; fluctuations in quarterly revenues due to
lengthy sales and implementation cycles for certain of our
solutions; our fixed expenses in relation to fluctuating revenues
and variations in customers' budget cycles; dependence on certain
major customers; changes in demand for our products and services
attributable to any weakness experienced in the economy or mergers,
acquisitions and consolidations in the pharmaceutical industry;
successful and timely development and introduction of new products
and versions; rapid technological changes; increased competition;
international operations; integrating the entities we acquire; our
ability to effectively manage our growth; the protection of our
proprietary technology; our ability to compete in the
Internet-related products and services market; the continued demand
for Internet-related products and services; the ability of our
third party vendors to respond to technological change; our ability
to maintain our relationships with third-party vendors; less
favorable than anticipated results from strategic relationships;
dependence of data solutions on strategic relationships; events
which may affect the U.S. and world economies; and catastrophic
events which could negatively affect our information technology
infrastructure. Other important factors that should be reviewed and
carefully considered are included in the company's 10-K, 10-Qs, and
other reports filed with the SEC. Actual results may differ
materially. The company assumes no obligation for updating any such
forward-looking statements to reflect actual results, changes in
assumptions or other changes affecting such forward-looking
statements.
Dendrite (NASDAQ:DRTE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dendrite (NASDAQ:DRTE)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Dendrite International (MM) (NASDAQ): 0 recent articles
More Dendrite International, Inc. News Articles